You are here: Home » News-CM » Companies » News
Business Standard

Sun Pharma receives USFDA approval for generic Ganirelix Acetate Injection

Capital Market 

Industries has received final approval from US for its (ANDA) for generic version of Acetate Injection, 250 mcg/0.5

The generic version is therapeutic equivalent to Organon's Acetate Injection, 250 mcg/0.5 As per IQVIA, Acetate Injection, 250 mcg/0.5 had annual sales of approximately US$ 67 million in the US for the 12 months ended September 2018.

The commercialization of this product in the US market is expected in Q4FY19.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, December 03 2018. 09:17 IST